US · Healthcare

Marizyme Inc (MRZM)

Biotechnology

Marizyme Inc (MRZM) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MRZM

P/E ratio

18.00

Marizyme Inc (MRZM) — FAQ

What is MRZM's P/E ratio?

The price-to-earnings (P/E) ratio for Marizyme Inc (MRZM) is 18.00 (data as of 2026-03-24).

Does Marizyme Inc pay a dividend?

Dividend yield is not available in the current snapshot for Marizyme Inc (MRZM). Check the MyAverix Finance app for the latest dividend data.

What sector is Marizyme Inc in?

Marizyme Inc (MRZM) is classified in the Healthcare sector (Biotechnology industry).

What exchange is MRZM listed on?

MRZM is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)